1-5 of 5
Michael Bayne
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

LYMRIT 37-01: A Phase I/II Study of 177 lu-Lilotomab Satetraxetan (Betalutin ® ) Antibody-Radionuclide-Conjugate (ARC) for the Treatment of Relapsed Non-Hodgkin's Lymphoma (NHL) — Analysis with 6-Month Follow-up

Arne Kolstad, MD PhD, Ulf Madsbu, MD, Matthew Beasley, MD, Michael Bayne, MD, Tim M. Illidge, MDPhD, Noelle O'Rourke, MD, Ingemar Lagerlöf, MD, Roman Hajek, MD PhD, Wojciech Jurczak, MD PhD, Ella Willenbacher, MD, Unn Merete Fagerli, MD PhD, Aleš Obr, MD, Johan Blakkisrud, MSc, Ayca Muftuler Løndalen, MD, Lisa Rojkjaer, MD, Åse Østengen, Nils Bolstad, MD, Signe Spetalen, MD, Martin Erlanson, MD PhD, Renate Galleberg, MD, Stine Nygaard Rudå, Harald Holte, Jr., MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2879.
https://doi.org/10.1182/blood-2018-99-110555
Published: 2018
Journal Articles

177 Lu-Lilotomab Satetraxetan, a Novel CD37-Targeted Antibody-Radionuclide Conjugate in Relapsed Non-Hodgkin's Lymphoma (NHL): Updated Results of an Ongoing Phase I/II Study (LYMRIT 37-01)

Arne Kolstad, MD PhD, Ulf Madsbu, MD, Matthew Beasley, MD, Michael Bayne, MD, Tim M. Illidge, MDPhD, Noelle O'Rourke, MD, Ingemar Lagerlöf, MD, Roman Hájek, MD, Wojciech Jurczak, PhDMD, Ella Willenbacher, MD, Johan Blakkisrud, MSc, Ayca Muftuler Løndalen, MD, Lisa Rojkjaer, MD, Laurie Baylor Curtis, MSc, Marianne Bloma, MSc, Simon Turner, PhD, Nils Bolstad, MD, Signe Spetalen, MD, Martin Erlanson, MD PhD, Unn Merete Fagerli, MD, Renate Galleberg, MD, Stine Nygaard Rudå, Harald Holte
Journal: Blood
Blood (2017) 130 (Supplement 1): 2769.
https://doi.org/10.1182/blood.V130.Suppl_1.2769.2769
Published: 2017
Journal Articles

177 lu-Satetraxetan-Lilotomab in the Treatment of Patients with Indolent Non-Hodgkin B-Cell Lymphoma (NHL), Phase 1/2 Safety and Efficacy Data from Four Different Pre-Dosing Regimens

Arne Kolstad, MD PhD, Ulf Madsbu, Matthew Beasley, Michael Bayne, Tim Illidge, Noelle O'Rourke, Caroline Stokke, Tore Bach-Gansmo, Ayca Muftuler Løndalen, Jon Erik Holtedahl, Mona Elisabeth Revheim, Øyvind Bruland, Jostein Dahle, Laurie Baylor Curtis, Åse Østengen, Simon Turner, Nils Bolstad, Roy Hartvig Larsen, Signe Spetalen, Martin Erlanson, Stine Nygaard Rudå, Harald Holte
Journal: Blood
Blood (2016) 128 (22): 1780.
https://doi.org/10.1182/blood.V128.22.1780.1780
Published: 2016
Journal Articles

The Health Related Quality of Life Is Maintained Following Treatment of Indolent Non-Hodgkin's Lymphoma Patients with the Novel Effective Antibody Radionuclide Conjugate 177 lu-Satetraxetan-Lilotomab

Arne Kolstad, MD PhD, Matthew Beasley, Michael Bayne, Ingemar Lagerlöf, Noelle O'Rourke, Jostein Dahle, Laurie Baylor Curtis, Åse Østengen, Simon Turner, Roy Hartvig Larsen, Harald Holte
Journal: Blood
Blood (2016) 128 (22): 5339.
https://doi.org/10.1182/blood.V128.22.5339.5339
Published: 2016
Journal Articles

Fractionated 90 y Ibritumomab Tiuxetan (Zevalin™) Radioimmunotherapy As An Initial Therapy of Follicular Lymphoma – First Results From a Phase II Study in Patients Requiring Treatment According to GELF/BNLI Criteria

Timothy M Illidge, MD, PhD, Ruth Pettengell, MD, Michael Bayne, MD, Steven Le Gouill, MD, PhD, Andrew Bates, MD, John Radford, MD, Jill Tipping, PhD, Maureen Zivanovic, PhD, Françoise kraeber-Bodere, MD, Emmanuel Malek, PhD, Huglo Damien, MD, Franck Morschhauser, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 102.
https://doi.org/10.1182/blood.V118.21.102.102
Published: 2011